Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD
Completed
Obsessive Compulsive Foundation
N/A
2006-08-01
The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective
when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance
(loss of therapeutic effect) to the medication will not develop over a period of several
weeks.
Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD
Completed
Stanford University
N/A
2006-08-01
The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective
when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance
(loss of therapeutic effect) to the medication will not develop over a period of several
weeks.
The overarching goal of this project is to have a consolidated consent and evaluation
procedure that will lead potential subjects to the most appropriate clinical trial or human
laboratory study (and its consent process) for their presenting concerns or interests. A
second purpose is to have a consolidated intake data base on which secondary analyses can be
conducted.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.